The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
Official Title: Perioperative Versus Adjuvant FOLFIRINOX for Resectable Pancreatic Cancer: the PREOPANC-3 Study
Study ID: NCT04927780
Brief Summary: The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients with resectable pancreatic cancer will be randomly assigned (1:1) to 8 cycles of neoadjuvant mFOLFIRINOX followed by surgery and 4 cycles of adjuvant mFOLFIRINOX (arm 1) or to upfront surgery followed by 12 cycles of adjuvant mFOLFIRINOX (arm 2). The primary objective of the trial is to determine whether perioperative mFOLFIRINOX improves overall survival compared with adjuvant mFOLFIRINOX in patients with resectable pancreatic cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Jeroen Bosch Hospital, 's-Hertogenbosch, , Netherlands
Meander Medical Center, Amersfoort, , Netherlands
Amsterdam UMC, Amsterdam, , Netherlands
OLVG, Amsterdam, , Netherlands
Amphia Hospital, Breda, , Netherlands
Deventer Hospital, Deventer, , Netherlands
Catharina Hospital, Eindhoven, , Netherlands
Medisch Spectrum Twente, Enschede, , Netherlands
University Medical Center Groningen, Groningen, , Netherlands
Tjongerschans Hospital, Heerenveen, , Netherlands
Medical Center Leeuwarden, Leeuwarden, , Netherlands
Leiden University Medical Center, Leiden, , Netherlands
Maastricht UMC+, Maastricht, , Netherlands
Radboud University Medical Center, Nijmegen, , Netherlands
Erasmus MC University Medical Center, Rotterdam, , Netherlands
Maasstad Ziekenhuis, Rotterdam, , Netherlands
Regional Academic Center Utrecht, Antonius Hospital, Utrecht, , Netherlands
Isala Hospital, Zwolle, , Netherlands
Oslo University Hospital, Oslo, , Norway
Sahlgrenska University Hospital, Gothenburg, , Sweden
Skåne University Hospital, Lund, , Sweden
Karolinska University Hospital, Stockholm, , Sweden
Name: Bas Groot Koerkamp, MD, PhD
Affiliation: Erasmus MC University Medical Center
Role: PRINCIPAL_INVESTIGATOR